Urinary-type plasminogen activator receptor (uPAR) modulates oral cancer cell behavior with alteration in p130cas - Zonggao Shi; Yueying Liu; Jeffrey J. Johnson; M. Sharon Stack (Molecular and Cellular Biochemistry, 2011)

WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics - Steven M. Grauer; Radka Graf; Rachel Navarra; Amy Sung; Sheree F. Logue; Gary Stack; Christine Huselton; Zhi Liu; Thomas A. Comery; Karen L. Marquis; Sharon Rosenzweig-Lipson (Psychopharmacology, 2009)

Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression - Laurie G. Hudson; Reema Zeineldin; M. Sharon Stack (Clinical & Experimental Metastasis, 2008)